SIGACHISigachi Industries Ltd.
Sigachi Industries Q2 FY27 Results: Consolidated Net Profit ₹8.78 Crore on Total Income of ₹131 Crore
- Earnings
- pharmaceuticals and chemicals
Reviewed byRachit TripathiBlacklitt Research
Sigachi Industries (NSE: SIGACHI) reported consolidated total income of ₹130.68 crore and net profit of ₹8.78 crore for the quarter ended 30 Sep 2026, it said in a filing on 31 Oct 2026. Standalone total income was ₹113.70 crore and standalone net profit ₹8.98 crore.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹130.68 crore, up 15.7% YoY and 6.9% QoQ
- Net profit and EPS: ₹8.78 crore, down 16.6% YoY and up 7.8% QoQ; basic EPS ₹0.27
- Finance costs: ₹3.85 crore, up 22.9% YoY and 27.7% QoQ
Standalone
The company on its own, without its subsidiaries
- Total income: ₹113.70 crore, up 31.5% YoY and 15.2% QoQ
- Net profit and EPS: ₹8.98 crore, down 23.7% YoY and up 38.0% QoQ; basic EPS ₹0.23
- Finance costs: ₹3.16 crore, up 25.2% YoY and 44.7% QoQ
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 130.68 | 112.98 | +15.7% | 122.28 | +6.9% | |
| Revenue from operations | 130.46 | 110.48 | +18.1% | 121.27 | +7.6% |
| Other income | 0.22 | 2.49 | -91.0% | 1.00 | -77.7% |
| 8.78 | 10.53 | -16.6% | 8.14 | +7.8% | |
| Profit before tax | 11.07 | 7.44 | +48.8% | 10.09 | +9.7% |
| Finance costs | 3.85 | 3.13 | +22.9% | 3.01 | +27.7% |
| Depreciation | 4.42 | 4.11 | +7.6% | 4.41 | +0.1% |
| Tax expense | 2.28 | -3.10 | n/a | 1.95 | +17.5% |
| Net profit margin | 6.72% | 9.32% | -2.60 pp | 6.66% | +0.06 pp |
| EPS, basic (₹) | 0.27 | 0.28 | -3.6% | 0.18 | +50.0% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Income grew faster than profit against the year-ago quarter. Revenue from operations rose 18.1% to ₹130.46 crore, while other income fell to ₹0.22 crore from ₹2.49 crore, so other income is now 0.2% of total income. Net profit fell 16.6% to ₹8.78 crore, even though profit before tax rose 48.8% to ₹11.07 crore. The gap sits in tax: the company booked a tax expense of ₹2.28 crore against a tax credit of ₹3.10 crore a year earlier.
The year-ago quarter carried an exceptional profit of ₹4.66 crore, as stated in the filing, so the year-ago base is not a clean comparison. The filing does not give the reason for that exceptional item.
Finance costs rose 22.9% YoY to ₹3.85 crore and 27.7% QoQ, which is 2.9% of total income. The filing does not give a reason for the rise.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 113.70 | 86.44 | +31.5% | 98.72 | +15.2% | |
| Revenue from operations | 113.48 | 83.94 | +35.2% | 98.28 | +15.5% |
| Other income | 0.22 | 2.49 | -91.2% | 0.44 | -50.5% |
| 8.98 | 11.76 | -23.7% | 6.51 | +38.0% | |
| Profit before tax | 10.51 | 7.97 | +31.9% | 7.79 | +34.9% |
| Finance costs | 3.16 | 2.53 | +25.2% | 2.19 | +44.7% |
| Depreciation | 3.62 | 3.31 | +9.3% | 3.62 | 0.0% |
| Tax expense | 1.54 | -3.79 | n/a | 1.29 | +19.4% |
| Net profit margin | 7.90% | 13.61% | -5.71 pp | 6.59% | +1.30 pp |
| EPS, basic (₹) | 0.23 | 0.31 | -25.8% | 0.17 | +35.3% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone total income rose 31.5% YoY to ₹113.70 crore, faster than consolidated income. Revenue from operations rose 35.2% to ₹113.48 crore.
Consolidated net profit is ₹0.20 crore lower than standalone. Standalone net profit rose 38.0% QoQ, faster than consolidated net profit, which rose 7.8%.
Standalone finance costs were ₹3.16 crore, 2.8% of total income. The filing does not give a reason for the rise in finance costs.
The filing says the board approved the results on 31 Oct 2026, and the auditor, Yelamanchi & Associates, issued a limited review report on both sets of results with no modification. The consolidated results include Sigachi US INC, Sigachi MENA FZCO and Trimax Bio Sciences Private Limited.
The filing notes an exceptional loss of ₹116.35 crore in the half year ended 30 Sep 2025 in both statements; the filing does not give its cause. Paid-up equity share capital is ₹38.21 crore at face value of ₹1 a share.
Net IPO proceeds of ₹89.70 crore are to be utilised, of which ₹32.30 crore for a CCS project at Dahej, Gujarat, is shown as unutilised. Blacklitt data puts the company's market value at ₹1,007 crore, and its latest reported quarter (Q1 FY27) at a consolidated net profit of ₹8.14 crore.
Inference
The board has proposed two appointments: Awanindra Kumar Singh as Additional Whole-Time Director (Professional, Executive) and Sridhara Narasimha Sastry as Additional Independent Director (Non-Executive), each effective 31 Oct 2026 subject to members' approval. The filing sets out a postal ballot notice for both. The filing does not say when the ballot will be held or whether members have approved the appointments, and it does not give the reason for the exceptional items in the year-ago periods.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.